SISTERS: Spasticity In Stroke Study - Randomized Study
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To demonstrate that Intrathecal Baclofen (ITB) Therapy, compared to Best Medical Treatment
(BMT), has superior efficacy in the treatment of severe spasticity in adult post-stroke
patients with generalized spastic hypertonia who have not reached their therapy goal with
other treatment interventions assessed by a decrease in the average Ashworth Scale (AS) score
in the lower extremities.
Phase:
Phase 4
Details
Lead Sponsor:
Medtronic International Trading Sarl MedtronicNeuro